SPECIALISED THERAPEUTICS AUSTRALIA PTY LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal 2019-10-14 14:00
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients 2019-08-05 20:00
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa 2019-06-04 06:39
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
New Early Breast Cancer Drug To Be Made Available In Singapore Via Special Access Program 2019-02-18 07:25
World-first Approval For Multiple Myeloma Drug APLIDIN(R) 2018-12-11 15:10
New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal 2017-11-22 22:30
Specialised Therapeutics Asia to License Promising Anti-Cancer Compound Lurbinectedin (PM1183) for South East Asia, Australia and New Zealand 2017-05-18 00:23
Novel Multiple Myeloma Drug Aplidin(R) Shows Positive Results in Pivotal Phase 3 Study 2016-03-31 16:32
Specialized Therapeutics Grants Sublicense for Anti-Emetic Products to Mundipharma for Australia and New Zealand 2016-03-07 22:00
1 2